FindTrial
Sign In

Gene evaluation for antihypertensive drug effects study

Gene evaluation for antihypertensive drug effects study - GEANE study

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-C000000119
Enrollment
300
Registered
2005-09-07
Start date
2004-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

essential hypertension

Interventions

thiazide diuretics indapamide calcium channel blocker amlodipine angiotensin II receptor blocker valsartan

Sponsors

National Cardiovascular Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: mild to moderate essential hypertension

Exclusion criteria

Exclusion criteria: severe hypertension (more than 180 and/or 110 mmHg) secondary hypertension female with pregnancy

Design outcomes

Primary

MeasureTime frame
gene polymorphisms relating to blood pressure lowering effect of thiazide diuretics, calcium channel blocker, angiotensin II receptor blocker—

Secondary

MeasureTime frame
gene polymorphisms relating to side effects of thiazide diuretics, calcium channel blocker, angiotensin II receptor blocker—

Countries

Japan

Contacts

Public ContactKei Kamide

National Cardiovascular Center Division of Hypertension and Nephrology

kamide@hsp.ncvc.go.jp06-6833-5012

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026